Therefore, inhibition of G9a in HCC overexpressing c‐Myc oncoprotein might be an alternate viable strategy to target c‐Myc since efforts to target c‐Myc with small molecules have been challenging [10]. This evidence concerns the gene EHMT2 and hepatocellular carcinoma.